SOLVO Biotechnology Recieves ISO 9001:2000 Quality Management System Certification
News Aug 21, 2007
SOLVO Biotechnology has announced that the company has received the UKAS accredited ISO 9001:2000 quality management system certification for the development and production of methods and reagents, contract research services.
As the leader in the development of membrane transporter assay systems SOLVO provides a wide array of in vitro ABC efflux, uptake transporter and monolayer assays as products and/or contract research services for industrial and academic organizations worldwide.
SOLVO’s solution packages answer important questions related to membrane transporters. Depending on the state of drug development pipeline SOLVO provides the adequate tool to answer transporter related concerns. High throughput membrane and cellular assays allow for inexpensive screening of large number of compounds during lead selection and optimization.
Lower throughput in vitro and in vivo assays can be used in preclinical candidate selection. Based on the Biopharmaceutical Drug Disposition Classification System SOLVO’s other assay selection scheme focuses on physicochemical properties of the compound, such as permeability and solubility.
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Computer Program Helps Find Ways to Repurpose Existing DrugsNews
Researchers have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, matches existing data about FDA-approved drugs to diseases, and predicts potential drug efficacy.READ MORE